GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Steris PLC (BSP:S1TE34) » Definitions » Forward PE Ratio

Steris (BSP:S1TE34) Forward PE Ratio : 26.12 (As of Nov. 13, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Steris Forward PE Ratio?

Steris's Forward PE Ratio for today is 26.12.

Steris's PE Ratio without NRI for today is 25.00.

Steris's PE Ratio (TTM) for today is 50.85.


Steris Forward PE Ratio Historical Data

The historical data trend for Steris's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Steris Forward PE Ratio Chart

Steris Annual Data
Trend 2020-12 2021-12 2022-09 2024-11
Forward PE Ratio
27.17 45.66 24.33 26.11

Steris Quarterly Data
2020-12 2021-03 2021-06 2021-09 2021-12 2022-03 2024-06 2024-09
Forward PE Ratio 27.17 26.11 28.09 33.33 45.66 40.82 23.53 26.04

Competitive Comparison of Steris's Forward PE Ratio

For the Medical Devices subindustry, Steris's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Steris's Forward PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Steris's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Steris's Forward PE Ratio falls into.



Steris Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Steris  (BSP:S1TE34) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Steris Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Steris's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Steris Business Description

Traded in Other Exchanges
Address
5960 Heisley Road, Mentor, OH, USA, 44060
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.

Steris Headlines

No Headlines